Cafepharma Daily Premium (On-Demand) Archive for November, 2018

Click a link below to view the mailing archive as if it had been sent to you.

2018-11-30 15:03		CP Friday Premium: AbbVie cuts another Humira biosim deal
2018-11-30 14:58		CP Thursday Evening Premium: Non-profit heads on pharma boards
2018-11-29 12:28		CP Thursday Premium: Bayer to axe 12,000 jobs
2018-11-29 00:19		CP Wednesday Premium: ViaCyte raises money for stem cell diabetes treatment trial
2018-11-28 13:07		CP Wednesday Premium: Pfizer wins Lyrica patent extension for pediatric patients
2018-11-27 23:53		CP Tuesday Evening Premium: Amarin raising funds pre-Vascepa push
2018-11-27 13:33		CP Tuesday Premium: Vertex Pharma positive trial -- Bristol negative trial
2018-11-26 23:39		CP Monday Evening Premium: How AI is changing respiratory care
2018-11-26 13:27		CP Monday Premium: Vectura's asthma treatment fails key trial
2018-11-25 23:42		CP Sunday Premium
2018-11-24 23:39		CP Premium Saturday
2018-11-21 13:32		CP Wednesday: Novartis still confident in Gilenya
2018-11-21 00:43		CP Tuesday Evening Premium: Sobi gets FDA nod
2018-11-20 13:18		CP Tuesday Premium: One more hurdle for Takeda's Shire purchase
2018-11-19 23:48		CP Monday Evening Premium: Another IPO - Genfit
2018-11-19 12:31		CP Monday Premium: Is AZ looking for a replacement for CEO Soriot?
2018-11-18 23:45		CP Sunday Premium: Where will Pfizer be in 5 years?
2018-11-17 15:19		CP Saturday Premium: Artificial intelligence and genomics
2018-11-16 20:38		CP Friday Evening Premium: Pfizer announces price hikes on 41 drugs
2018-11-16 13:57		CP Friday Premium: Is AZ's CEO overpaid?
2018-11-15 23:54		CP Thursday Evening Premium: What drugs surprised in Q3
2018-11-15 14:44		CP Thursday Premium: No spinoff for Novartis' Sandoz
2018-11-14 23:49		CP Wednesday Evening Premium: Pfizer launches third biosimilar
2018-11-14 13:18		CP Wednesday Premium: Novartis files for Alcon spinoff + IPOs
2018-11-14 00:05		CP Tuesday Evening Premium: AbbVie to boost Mavyret access
2018-11-13 13:08		CP Tuesday Premium: Walmart and Home Depot join drug copay battle
2018-11-13 00:00		CP Monday Evening Premium: Generics, cancer drugs, and more
2018-11-12 12:46		CP Monday Premium: New company from Takeda-Shire buyout to debut in Jan
2018-11-11 21:21		CP Sunday Premium: New data for Vascepa
2018-11-10 13:02		CP Saturday Premium: NASH drugs, AI, IPOs, Takeda-Shire buyout and more
2018-11-09 15:09		CP Friday Premium: Genentech said Sanofi partner used trade secrets to develop drugs
2018-11-09 00:12		CP Thursday Evening Premium: PARP inhibitors
2018-11-08 13:47		CP Thursday Premium: AZ finally reports good sales growth
2018-11-07 23:19		CP Wednesday Evening Premium: AbbVie staves off another Humira copy
2018-11-07 12:56		CP Wednesday Premium: Newly Democratic House to focus on drug prices
2018-11-07 00:07		CP Tuesday Evening Premium: Election Night impact
2018-11-06 13:27		CP Tuesday Premium: AZ divests some assets
2018-11-06 00:31		CP Monday Evening Premium: Novartis' $4 million priced drug
2018-11-05 14:01		CP Monday Premium: Lilly's Trulicity shows some cardiac protection
2018-11-04 14:55		CP Sunday Premium: Amarin, Geron, and upcoming earnings
2018-11-03 16:16		CP Saturday Premium: More FDA actions and EpiPen issues
2018-11-02 21:38		CP Friday Evening Premium: FDA approvals...including a controversial one
2018-11-02 12:23		CP Friday Premium: Novo Nordisk cuts increase to 1300
2018-11-01 23:27		CP Thursday Evening Premium: Illumina to acquire Pacific Biosciences
2018-11-01 13:25		CP Thursday Premium: Sanofi and Denali in development pact

<< Archive Index • Subscribe >>

Cafepharma Daily Premium (On-Demand) Archive for November, 2018

Contact Us

Past Issues

Unsubscribe